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The field of neuroimmunology is providing growing evidence
of active crosstalk between the immune system and the
nervous system in health and during diverse pathological
conditions. Experimental and clinical research now sug-
gests that signaling from periphery to brain is important
for maintaining homeostasis, but also has the potential to
impact brain disease initiation or progression. Knowledge
and understanding of the cellular andmolecularmechanisms
governing immune-to-brain bidirectional communication is
providing key insights to better model neuroimmune com-
munication, understand the clinical implications, and design
better therapies for CNS disorders with an inflammatory
component.
This special issue contains 16 papers, representing original
research articles, clinical research articles, and reviews, rang-
ing from detailed studies of the key molecular determinants
of the neuroinflammatory reaction to the complex neuroim-
mune component of diverse neurological diseases.
“Systemic immune activation leads to neuroinflammation
and sickness behavior inmice” by S. Biesmans et al. describes a
study that investigates the effect of systemic LPS administra-
tion on the CNS by assessing changes of glial cells, cytokine
production, and various behavioural tasks. The use of GFAP-
luc mice provides novel insight into the glial response to
systemic inflammation. The study also provides insights into
the kinetics of behavioural changes in response to systemic
inflammation, when measured in the same subject. “Immune
privilege as an intrinsic CNS property: astrocytes protect
the CNS against T-cell-mediated neuroinflammation” by U.
Gimsa et al. is a review of the literature on neuroimmune
interactions between CNS astrocytes and peripheral T cells
that attempt to gain access into the CNS.This review provides
evidence of these astrocyte-T cell interactions in both health
and disease. The authors discuss mechanisms by which
astrocytes regulate T cells to help direct both pro- and
anti-inflammatory responses. Overall, the authors review the
evidence that astrocytes regulate T cells at multiple check
points to help ensure neuroprotection andmaintenance of an
anti-inflammatory environment within the CNS. “Activation
of protease-activated receptor 2-mediated signaling bymast cell
tryptase modulates cytokine production in primary cultured
astrocytes” byX. Zeng et al. is an original article that examined
the role of tryptase, which is a protease-activated receptor
(PAR)-2 agonist. Tryptase is produced by mast cells and
activates the PAR-2 receptor. The authors show evidence that
tryptase increased IL-6 and TNF-a production by primary
astrocytes. Antagonism of PAR-2 prevented the induction
of these cytokines by primary astrocytes. Moreover, the
authors outlined two different signaling pathways by which
tryptase promotes IL-6 (PI3-kinase dependent) and TNF in
astrocytes (P38/JNK-kinase dependent). Taken together this
data highlight a way in which peripheral immune cells (i.e.,
mast cells) can functionally communicate with astrocytes
and potentially influence inflammatory responses within the
CNS. “ATP is required and advances cytokine-induced gap
junction formation in microglia in vitro” by P. J. Sa´ez et al.
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reports on the effects of ATP on microglial cells. In this
research article the authors use an in vitro approach to
study the function of microglial hemichannels and gap
junction channels, and their data support the idea that
extracellularATP affects the cellular communication between
microglia through autocrine and paracrine mechanisms.
“Possible involvement of TLRs and hemichannels in stress-
induced CNS dysfunction via mastocytes, and glia activation”
by A. Aguirre et al. reviews the involvement of a TLR-
mediated pathway to control neuroinflammatory responses
within the CNS. The authors suggest that mastocytes and
glial cells sense the inflammatory tone, via TLR activation,
driving the release of inflammatory mediators and further
amplification of neural damage.
A significant part of this special issue is devoted to the
study ofmultiple sclerosis, as a paradigmof immune-to-brain
communication. “Persistent inflammation in the CNS during
chronic EAE despite local absence of IL-17 production” by S. F.
G. Zorzella-Pezavento et al. describes a study that investigates
the role of proinflammatory cytokines in immune infiltrates
during the acute and chronic diseases stages of experimental
allergic encephalitis (EAE). The results show that the levels
of IFN-g are elevated in the periphery and CNS in both
the acute and chronic stages of disease. In contrast, IL-17
is only found in the CNS at the acute stages; the authors
suggest that this is due to a decline in Treg cells in the CNS
at the chronic phase. The study did not investigate the role
of myeloid cells, which may be an alternative explanation
for persisting infiltrates in the CNS, despite the lack of IL-17.
“Local overexpression of interleukin-11 in the central nervous
system limits demyelination and enhances remyelination” by
A. Maheshwari et al. provides evidence that IL-11 promotes
remyelination in the cuprizone model of demyelination
associated with reduced microglial activation. It remains to
know whether the effect of IL-11 on myelination is direct or
indirect via microglia/macrophages. “Growth arrest specific
gene 6 protein concentration in cerebrospinal fluid correlates
with relapse severity in multiple sclerosis” by P. P. Sainaghi et
al. reports a clinical study that shows a correlation of Gas-
6 in CSF with the severity of relapse in relapsing-remitting
multiple sclerosis patients. However, the Gas-6 levels in CSF
were not predictive for the long-term outcomes. “Regulation
of immune cell infiltration into the CNS by regional neural
inputs explained by the gate theory” by Y. Arima et al. reviews
the modes of infiltration of immune cells into the CNS
parenchyma. In particular, the authors propose the “gate
theory” as an alternative explanation for the control of cell
extravasation into the CNS in pathological conditions such
as multiple sclerosis.
Some articles focus on the study of the neuroimmune
component of neurodegenerative diseases such as Alzheim-
er’s or Parkinson’s, or other brain diseases. “Role of scavenger
receptors in glia-mediated neuroinflammatory response as-
sociated with Alzheimer’s disease” by F. Cornejo and R.
von Bernhardi is a detailed review about the inflammatory
mechanisms mediated by microglia and astroglia on the
pathological events in the Alzheimer’s disease, emphasizing
the relevance of A scavenger receptors for Ab clearance. “Role
of neuroinflammation in adult neurogenesis and Alzheimer
disease: therapeutic approaches” by A. Fuster-Matanzo et al.
reviews the influence of the neuroinflammatory component
of Alzheimer’s disease over the regulation of adult neu-
rogenesis, aiming at summarizing the reported effects of
several inflammatory mediators and finding new avenues
into potential therapeutic interventions. “Cellular and molec-
ular mediators of neuroinflammation in the pathogenesis of
Parkinson’s disease” by S. V. More et al. reviews the current
evidence supporting a detrimental role of microglial cells
during the pathogenesis of Parkinson’s disease. Current evi-
dence from human studies highlights the neurotoxic activity
of diverse inflammatory mediators or infiltrated immune
cells in Parkinson’s disease, although further experimental
evidence is needed to fully understand the neuroinflam-
matory reaction in this pathology. “MMP-3 contributes to
nigrostriatal dopaminergic neuronal loss, BBB damage, and
neuroinflammation in an MPTP mouse model of Parkinson’s
disease” byY. C. Chung et al. is an original research article that
examined the role of metalloproteases 3 (MMP3) in a mouse
model of Parkinson disease. These authors provide novel
evidence that matrix MMP3 plays a key role in increased
leukocyte infiltration and dopaminergic cell loss after MPTP.
For instance, MMP3 knockout mice had attenuated damage
to the blood brain barrier (BBB), reduced infiltration of ED-
1+ and CD3+ leukocytes, and reduced neuronal loss. More-
over, motor function was maintained in theMMP3 knockout
mice after MPTP injection compared to the wildtype MPTP-
injected mice.Thus, MMP3-mediated breakdown of the BBB
and enhanced leukocyte infiltration into the brain play a sig-
nificant role in nigrostriatal dopaminergic neuronal loss after
MPTP. “Are onconeural antibodies a clinical phenomenology
in paraneoplastic limbic encephalitis?” by H. Zhang et al. is a
detailed review about the role of brain-specific antibodies in
neurological diseases and in particular those associated with
peripheral malignancies. “The causative pathogen determines
the inflammatory profile in cerebrospinal fluid and outcome
in patients with bacterial meningitis” by D. Grandgirad et al.
is a clinical study that examined cerebrospinal fluid (CSF)
frompatients withmeningitis caused by one of three different
pathogens (Streptococcus pneumonia, Neisseria mengitidis, or
Haemophilus influenza). The authors’ findings indicate that
pneumococcal meningitis was associated with high levels of
inflammatory mediators in the CSF including IFN-𝛾, MCP-1,
and MM9. Furthermore, the higher rates of fatal outcome in
patients with pneumococcal meningitis were associated with
correspondingly high levels of proinflammatory cytokines in
the CSF including TNF-𝛼, IL-1𝛽, and IL-6. Overall, patients
with pneumococcal meningitis had an elevated CNS inflam-
matory response and higher mortality rate than patients
with either Neisseria mengitidis or Haemophilus influenza.
“Prognostic value of inflammatorymediators in 1-year outcome
of acute ischemic stroke with middle cerebral artery stenosis”
by X. Gong et al. is a clinical study reporting the prognostic
value of diverse inflammatory mediators in ischemic stroke.
Elevated hs-CRP was found to predict 1-year poor outcome
in acute stroke.The combination of increased hs-CRP, WBC,
or HCY had a stronger predictive value in poor outcome than
individual elevated mediator.
Mediators of Inflammation 3
Acknowledgments
We would like to acknowledge the authors for their excellent
contributions and constructive work. We would also like to
express our gratitude to all the reviewers on these articles, for
their kind assistance and helpful insights.
Diego Gomez-Nicola
Jessica Teeling
Carmen Guaza
Jonathan P. Godbout
Dennis D. Taub
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
